Nanomilling: Enhancing Drug Solubility And Bioavailability

Poor water solubility remains one of the most common barriers to successful drug development, often limiting bioavailability and therapeutic performance. Nanomilling offers a practical solution by reducing API particle size to the nanometer scale, increasing surface area and accelerating dissolution rates for improved absorption.

This infographic highlights how nanomilling helps address formulation challenges for poorly soluble compounds, particularly BCS Class II drugs. Key benefits include enhanced bioavailability, broader formulation flexibility across oral, injectable, inhalable, and buccal delivery routes, and scalable manufacturing processes that support consistent product quality. It also provides an overview of the nanomilling workflow, from identifying solubility challenges and reducing particle size to formulation optimization and final packaging.

For drug developers seeking strategies to improve performance while maintaining manufacturing efficiency, nanomilling represents an increasingly valuable tool in the formulation toolkit. Explore the full infographic to learn how advanced particle size reduction technologies are helping accelerate pharmaceutical development.